Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use

被引：1
|
作者：
Carrieri, Patrizia [1 ]
Duracinsky, Martin [2 ,3 ,4 ]
Marcellin, Fabienne [1 ]
Lazarus, Jeffrey V. [5 ]
机构：
[1] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France
[2] Bicetre Hosp, AP HP, Internal Med & Clin Immunol Dept, Le Kremlin Bicetre, France
[3] Hop Hotel Dieu, AP HP, Hlth Econ Clin Trial Ctr, Paris, France
[4] Univ Paris Diderot, Patient Ctr Outcomes Res, EA7334, Paris, France
[5] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain
来源：
HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1002/hep.30356
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [31] Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair
    Tacke, Frank
    Arrese, Marco
    Sharma, Barjesh Chander
    Mostafa, Ibrahim
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Yilmaz, Yusuf
    George, Jacob
    Fan, Jiangao
    Vos, Miriam B.
    HEPATOLOGY, 2019, 69 (06) : 2672 - 2682
  • [32] Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Sakamoto, Michiie
    Tsujikawa, Hanako
    Effendi, Kathryn
    Ojima, Hidenori
    Harada, Kenichi
    Zen, Yoh
    Kondo, Fukuo
    Nakano, Masayuki
    Kage, Masayoshi
    Sumida, Yoshio
    Hashimoto, Etsuko
    Yamada, Gotaro
    Okanoue, Takeshi
    Koike, Kazuhiko
    PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 1 - 7
  • [33] Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Kogachi, Shannon
    Noureddin, Mazen
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 455 - 472
  • [34] Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Shahinul Alam
    Sheikh Mohammad Noor-E-Alam
    Ziaur Rahman Chowdhury
    Mahabubul Alam
    Jahangir Kabir
    World Journal of Hepatology, 2013, (05) : 281 - 287
  • [35] Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Alam, Shahinul
    Noor-E-Alam, Sheikh Mohammad
    Chowdhury, Ziaur Rahman
    Alam, Mahabubul
    Kabir, Jahangir
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (05) : 281 - 287
  • [36] DEVELOPMENT OF A CONCEPTUAL FRAMEWORK FOR ASSESSING DISEASE-SPECIFIC PATIENT-REPORTED OUTCOMES IN NONALCOHOLIC STEATOHEPATITIS
    Palsgrove, A. C.
    Hazra, S.
    Ferguson, B.
    Cheng, R.
    Cole, J. C.
    VALUE IN HEALTH, 2016, 19 (03) : A94 - A94
  • [37] Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
    Younossi, Zobair M.
    Marchesini, Giulio
    Pinto-Cortez, Helena
    Petta, Salvatore
    TRANSPLANTATION, 2019, 103 (01) : 22 - 27
  • [38] Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis Sarcopenia and Nonalcoholic Fatty Liver Disease
    Kawaguchi, Takumi
    Takahashi, Hirokazu
    Gerber, Lynn H.
    CLINICS IN LIVER DISEASE, 2023, 27 (02) : 275 - 286
  • [39] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Yilmaz, Y.
    Ayyildiz, T.
    Akin, H.
    Colak, Y.
    Ozturk, O.
    Senates, E.
    Tuncer, I.
    Dolar, E.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
  • [40] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Keiichiro Sugimoto
    Hiroshi Inui
    Toshio Fukusato
    World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785
12345